Cryoport, Inc. 8-K Filing Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cryoport, Inc. on February 25, 2010, reporting events occurring on February 19, 2010, and February 23, 2010. The filing details a material definitive agreement regarding the company's outstanding debt obligations.
Key Financial Metrics and Debt Structure
The filing does not provide standard financial metrics such as revenue, profit, cash flow, or operating margins. The primary financial data relates to the restructuring of the company's debt:
- Debt Instrument: Original Issue Discount 8% Senior Secured Convertible Debentures (dated 2007 and 2008) and associated warrants.
- Deferred Payments: Holders agreed to defer amortization payments of $200,000 each for January 1, 2010, and February 1, 2010, until March 1, 2010.
- Conversion Amount: Holders agreed to convert $1,357,215 of principal into common stock, contingent on a public offering.
- Future Payment Schedule: If the offering succeeds, principal and interest payments of $200,000 monthly will resume on March 1, 2011, for 17 months, with a final balloon payment due August 1, 2012.
- Interest Accrual: Future interest accruing from July 1, 2010, to March 1, 2011, will be capitalized (added to the principal balance).
Material Changes and Agreement Terms
The "February 2010 Amendment" (modified February 23, 2010) restructures the relationship between Cryoport and its debt holders (Enable Growth Partners, Enable Opportunity Partners, Pierce Diversified Strategy Master Fund, and BridgePointe Master Fund). Key changes include:
- Contingency on Capital Raise: The restructuring is conditional on Cryoport consummating a public offering of units (one share + one warrant) for gross proceeds of at least $5,000,000 at a price of not less than $3.00 per unit by March 15, 2010.
- Conversion Price Adjustment: The conversion price for remaining debt will be the lesser of the current $4.50 or the unit offering price.
- Warrant Adjustments: Warrant exercise prices will be adjusted to the lesser of $4.50 or the new offering warrant price. The exercise period is extended to January 1, 2015.
- Covenant Relief: Certain financial covenants and anti-dilution provisions (including the right to maintain 34.5% fully-diluted ownership) are terminated.
- Lock-Up Agreement: Holders agreed to an 180-day lock-up, with exceptions allowing sales if the stock price exceeds 200% (up to 10% of volume) or 300% (unlimited) of the offering price.
Outlook, Risks, and Contingencies
The filing outlines a critical contingency: if the $5,000,000 public offering is not consummated by March 15, 2010, at the specified price, the debt restructuring provisions (excluding the warrant extension) will be null and void. This creates a significant liquidity risk for the company, as the deferral of payments and debt conversion are dependent on successful capital raising.
Investor Verification Checklist
- Verify whether Cryoport successfully consummated the $5,000,000 public offering by March 15, 2010.
- Confirm the actual unit offering price to determine the final conversion price for the debt and warrants.
- Monitor the company's ability to resume $200,000 monthly payments starting March 1, 2011.
- Review subsequent filings for the status of the deferred $400,000 in amortization payments due March 1, 2010.
- Check for any updates on the termination of the 34.5% ownership maintenance right and its impact on existing shareholder dilution.